InvestorsHub Logo
Followers 53
Posts 1777
Boards Moderated 0
Alias Born 03/22/2015

Re: WeeZuhl post# 352544

Thursday, 03/04/2021 12:26:58 PM

Thursday, March 04, 2021 12:26:58 PM

Post# of 401774

Combining the extended release formula and the PEG-based hard shell to form a safe and effective ADF is no slam dunk, especially for a company that failed in 2 tries to get FDA approval for a simple oxyIR bead.






Maybe we could get a quick and easy NDA approval for an abuse-deterrent version of the immediate-release drug, as a proof of concept. Hmmm. Where have I heard this before?





Occam's razor: the simplest solution is most likely the right one.

Hanlon's razor: never attribute to malice that which is adequately explained by stupidity.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News